These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 11838587)

  • 1. Recurrent pneumonia due to persistent Chlamydia pneumoniae infection.
    Miyashita N; Fukano H; Hara H; Yoshida K; Niki Y; Matsushima T
    Intern Med; 2002 Jan; 41(1):30-3. PubMed ID: 11838587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-limiting pneumonia due to Chlamydia pneumoniae.
    Miyashita N; Fukano H; Mouri K; Fukuda M; Yoshida K; Kobashi Y; Niki Y; Oka M
    Intern Med; 2005 Aug; 44(8):870-4. PubMed ID: 16157990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of atypical pathogen: Mycoplasma pneumoniae and Chlamydia pneumoniae in the acute respiratory infection in childhood].
    Ouchi K
    Jpn J Antibiot; 2000 Jun; 53 Suppl B():13-21. PubMed ID: 12572086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chlamydia pneumoniae and other Chlamydia species in community-acquired pneumonia].
    Ruiz Carmona M; Soler Polcar N; Torres Martí A
    Rev Clin Esp; 1998 Sep; 198 Suppl 1():30-4. PubMed ID: 9835771
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapeutic approaches to Chlamydia infections.
    Senn L; Hammerschlag MR; Greub G
    Expert Opin Pharmacother; 2005 Oct; 6(13):2281-90. PubMed ID: 16218888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Isolation of Chlamydia pneumoniae in atypical pneumonia].
    Maass M; Dalhoff K
    Dtsch Med Wochenschr; 1994 Oct; 119(43):1462-6. PubMed ID: 7956770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chlamydia pneumoniae pneumonia: role of new macrolides.
    Blasi F; Cosentini R; Tarsia P; Camusso L; Campi E; Arosio C; Allegra L
    J Chemother; 1995 Nov; 7 Suppl 4():117-8. PubMed ID: 8904128
    [No Abstract]   [Full Text] [Related]  

  • 8. Roentgenographic findings of pneumonia caused by Chlamydia pneumoniae. A comparison with streptococcus pneumonia.
    Kauppinen MT; Lähde S; Syrjälä H
    Arch Intern Med; 1996 Sep; 156(16):1851-6. PubMed ID: 8790080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbiological efficacy of ABT-773 (cethromycin) for the treatment of community-acquired pneumonia due to Chlamydia pneumoniae.
    Hammerschlag MR; Reznik T; Roblin PM; Ramirez J; Summersgill J; Bukofzer S
    J Antimicrob Chemother; 2003 Apr; 51(4):1025-8. PubMed ID: 12654764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe community-acquired pneumonia, shock and multiorgan dysfunction syndrome caused by Chlamydia pneumoniae.
    Marik PE; Iglesias J
    J Intern Med; 1997 May; 241(5):441-4. PubMed ID: 9183314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of acute Chlamydia pneumoniae infection with telithromycin in C57BL/6J mice.
    Törmäkangas L; Saario E; Bem David D; Bryskier A; Leinonen M; Saikku P
    J Antimicrob Chemother; 2004 Jun; 53(6):1101-4. PubMed ID: 15117927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chlamydia pneumoniae and Mycoplasma pneumoniae pneumonia in children].
    Iniguez JL
    Arch Pediatr; 1998; 5 Suppl 1():18s-21s. PubMed ID: 10223156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pneumonia due to Chlamydia pneumoniae: prevalence, clinical features, diagnosis, and treatment.
    Kauppinen M; Saikku P
    Clin Infect Dis; 1995 Dec; 21 Suppl 3():S244-52. PubMed ID: 8749673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of CEM-101, a new fluoroketolide antibiotic, against Chlamydia trachomatis and Chlamydia (Chlamydophila) pneumoniae.
    Roblin PM; Kohlhoff SA; Parker C; Hammerschlag MR
    Antimicrob Agents Chemother; 2010 Mar; 54(3):1358-9. PubMed ID: 20038627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Azithromycin in treatment of patients with asthma and C. Pneumoniae infection.
    Dokic D; Poposki B; Karkinski D
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2013; 34(2):71-7. PubMed ID: 24296633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbiologic efficacy of moxifloxacin for the treatment of community-acquired pneumonia due to Chlamydia pneumoniae.
    Hammerschlag MR; Roblin PM
    Int J Antimicrob Agents; 2000 Jul; 15(2):149-52. PubMed ID: 10854812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chlamydia pneumoniae respiratory infections among patients infected with the human immunodeficiency virus.
    Comandini UV; Maggi P; Santopadre P; Monno R; Angarano G; Vullo V
    Eur J Clin Microbiol Infect Dis; 1997 Oct; 16(10):720-6. PubMed ID: 9405940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chlamydia (Chlamydophila) pneumoniae pneumonia].
    Kishimoto T; Ogawa M; Shiga S
    Nihon Rinsho; 2003 Feb; 61 Suppl 2():490-5. PubMed ID: 12722268
    [No Abstract]   [Full Text] [Related]  

  • 19. Persistent Chlamydia pneumoniae infection in a Swedish family.
    Falck G; Gnarpe J; Gnarpe H
    Scand J Infect Dis; 1996; 28(3):271-3. PubMed ID: 8863360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of Chlamydia pneumoniae in clinical specimens by polymerase chain reaction using nested primers.
    Black CM; Fields PI; Messmer TO; Berdal BP
    Eur J Clin Microbiol Infect Dis; 1994 Sep; 13(9):752-6. PubMed ID: 7531141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.